Riskpilot← Back to searchSign inGet full accessNEMUS LØRENSKOG AS
ASActiveOrg 999668615Bibliotekgata 30, 1473 LørenskogOther human health activities n.e.c. · NACE 8699Est. 20131 employees
Revenue 2024
NOK 9,7M
+4% vs 2023
EBITDA margin
8.5%
+45% vs 2023
Equity ratio
8.2%
Financial strength
Net profit 2024
NOK 640K
+47% vs 2023
| Revenue | NOK 9,7M | +4% |
| EBITDA | NOK 821K | +45% |
| Net profit | NOK 640K | +47% |
| Total assets | NOK 2,2M | +24% |
| Equity | NOK 184K | +27% |
| Employees | 1 | — |
Legal name
NEMUS LØRENSKOG AS
Org number
999668615
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
9. februar 2013
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Utvikling og drift av tverrfaglig helserelatert virksomhet, herunder aksjer og verdipapirer samt alt som faller naturlig sammen med dette inkludert deltakelse i andre selskaper.
Address
Bibliotekgata 30, 1473 Lørenskog
Phone
+4767906662
Email
lorenskog@nemus.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 791 | 8 815 | 8 990 | 9 272 | 9 681 |
| Staff expenses | −2 985 | −2 225 | −2 218 | −2 284 | −2 012 |
| EBITDA | 774 | 723 | 472 | 566 | 821 |
| Depreciation & amort. | −5 | −5 | −0 | −0 | −0 |
| EBIT | 769 | 717 | 472 | 566 | 821 |
| Net financials | −1 | −0 | −0 | −0 | 3 |
| Profit before tax | 768 | 717 | 471 | 566 | 824 |
| Tax | 169 | 163 | 106 | 130 | 184 |
| Net profit | 599 | 554 | 365 | 436 | 640 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 784 | 2 628 | 2 925 | 1 813 | 2 246 |
| Equity | 1 011 | 38 | 109 | 145 | 184 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 773 | 2 590 | 2 816 | 1 669 | 2 062 |
| Total debt | 1 773 | 2 590 | 2 816 | 1 669 | 2 062 |
EBITDA margin
8.5%
This company
15.8%
Market median
-46% vs market
20202024
Equity ratio
8.2%
This company
38.2%
Market median
-79% vs market
20202024
Return on equity
347.0%
This company
18.4%
Market median
+1786% vs market
20202024
Net profit margin
6.6%
This company
8.1%
Market median
-19% vs market
20202024
Asset turnover
4.31×
This company
1.12×
Market median
+285% vs market
20202024
Debt / equity
11.19×
This company
0.62×
Market median
-1705% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2025 | |
| Chairman | 2021 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Former (1) | ||
| Chairman | 2013 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 95% | 95% | 2024 | |
| Company | 5% | 5% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
O2 Holding As
NEMUS LØRENSKOG AS Board members of NEMUS LØRENSKOG AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Magnus Lagerkvist | Chairman | 0 companies |
| Thor Helge Bergan | Chairman | 0 companies |
| Grete Kristin Bråten | Chairman | 0 companies |
| Trym Tuxen Ringkjøb Buvarp | Board of Directors | 0 companies |
| Mats Karl Johan Gunnarsson | Board of Directors | 0 companies |